NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel, first-in-class carbohydrate compounds, today announced that S. Colin Neill has been nominated to its Board of Directors. He has consented to serve if elected at the 2007 Annual Meeting of Stockholders. Mr. Neill is Senior Vice President, Chief Financial Officer, Secretary and Treasurer of Pharmos Corporation (Nasdaq: PARS), a developer of novel therapeutics to treat a range of diseases of the nervous system, including disorders of the brain-gut axis, with a focus on pain/inflammation, and autoimmune disorders.
